Castle Biosciences Ownership 2024 | Who Owns Castle Biosciences Now?
Institutional Ownership
22.11%
Insider Ownership
3.32%
Retail Ownership
74.57%
Institutional Holders
67.00
Castle Biosciences Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKROCK INC. | 11.08% | 0.00% | 3,044,973 | 449,286 | 17.31% | 66,289,062 | Jun 30, 2024 |
| WASATCH ADVISORS LP | 8.47% | 0.27% | 2,327,936 | -223,152 | -8.75% | 50,679,167 | Jun 30, 2024 |
| VANGUARD GROUP INC | 5.74% | 0.00% | 1,577,514 | 83,338 | 5.58% | 34,342,480 | Jun 30, 2024 |
| PRINCIPAL FINANCIAL GROUP INC | 5.45% | 0.02% | 1,498,143 | -34,329 | -2.24% | 32,614,493,000 | Jun 30, 2024 |
| BELLEVUE GROUP AG | 4.43% | 0.43% | 1,217,101 | -2,984 | -0.24% | 26,496,289 | Jun 30, 2024 |
| PORTOLAN CAPITAL MANAGEMENT, LLC | 4.41% | 2.17% | 1,210,952 | 167,542 | 16.06% | 26,362,425 | Jun 30, 2024 |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 3.85% | 0.92% | 1,058,941 | -568,283 | -34.92% | 23,053,146 | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3.18% | 0.32% | 874,609 | -53,408 | -5.76% | 19,040,238 | Jun 30, 2024 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 3.11% | 1.64% | 853,628 | 128,171 | 17.67% | 18,583,482 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 2.95% | 0.00% | 809,934 | 60,675 | 8.10% | 17,630,935 | Jun 30, 2024 |
| STATE STREET CORP | 2.25% | 0.00% | 619,077 | 13,278 | 2.19% | 13,477,306,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.25% | 0.00% | 617,679 | 39,145 | 6.77% | 13,449,891 | Jun 30, 2024 |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 1.98% | 0.22% | 542,874 | - | - | 11,818,367 | Jun 30, 2024 |
| PALISADE CAPITAL MANAGEMENT, LP | 1.96% | 0.32% | 537,974 | -9,193 | -1.68% | 11,711,688 | Jun 30, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1.88% | 0.05% | 517,977 | -13,925 | -2.62% | 11,276,359 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 1.67% | 0.00% | 460,000 | 460,000 | 100.00% | 10,014,200 | Jun 30, 2024 |
| BRAIDWELL LP | 1.51% | 0.28% | 416,100 | 416,100 | 100.00% | 9,058,497 | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | 1.13% | 0.00% | 309,511 | 46,703 | 17.77% | 6,738,054 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 1.10% | 0.01% | 301,500 | 96,800 | 47.29% | 6,563,655 | Jun 30, 2024 |
| AMERIPRISE FINANCIAL INC | 1.07% | 0.00% | 294,022 | -1,305 | -0.44% | 6,400,859 | Jun 30, 2024 |
Castle Biosciences's largest institutional shareholder is BLACKROCK INC., holding 11.08% of the company's total share outstanding, currently valued at $66.29M. The top 10 institutional shareholders own together 52.66% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ABG INNOVATION CAPITAL PARTNERS III GP LTD | 0.13% | 93.07% | 36,747 | 3,121 | 9.28% | 799,982 | Jun 30, 2024 |
| PORTOLAN CAPITAL MANAGEMENT, LLC | 4.41% | 2.17% | 1,210,952 | 167,542 | 16.06% | 26,362,425 | Jun 30, 2024 |
| PURA VIDA INVESTMENTS, LLC | 0.56% | 2.11% | 153,386 | 153,386 | 100.00% | 3,339,213 | Jun 30, 2024 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 3.11% | 1.64% | 853,628 | 128,171 | 17.67% | 18,583,482 | Jun 30, 2024 |
| YU FAN | 0.13% | 1.05% | 36,747 | 36,747 | 100.00% | 799,982 | Jun 30, 2024 |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 3.85% | 0.92% | 1,058,941 | -568,283 | -34.92% | 23,053,146 | Jun 30, 2024 |
| PARKMAN HEALTHCARE PARTNERS LLC | 1.01% | 0.81% | 277,895 | -89,513 | -24.36% | 6,049,774 | Jun 30, 2024 |
| BIRCHVIEW CAPITAL, LP | 0.12% | 0.69% | 34,000 | 20,000 | 142.86% | 740,180 | Jun 30, 2024 |
| PERKINS CAPITAL MANAGEMENT INC | 0.11% | 0.64% | 31,090 | -1,050 | -3.27% | 677,000 | Jun 30, 2024 |
| LISANTI CAPITAL GROWTH, LLC | 0.35% | 0.51% | 96,550 | 96,550 | 100.00% | 2,101,894 | Jun 30, 2024 |
| INTRINSIC EDGE CAPITAL MANAGEMENT LLC | 0.93% | 0.50% | 254,411 | 30,844 | 13.80% | 5,538,527 | Jun 30, 2024 |
| BELLEVUE GROUP AG | 4.43% | 0.43% | 1,217,101 | -2,984 | -0.24% | 26,496,289 | Jun 30, 2024 |
| NEXT CENTURY GROWTH INVESTORS LLC | 0.86% | 0.43% | 236,830 | 17,357 | 7.91% | 5,155,789 | Jun 30, 2024 |
| MILLRACE ASSET GROUP, INC. | 0.06% | 0.37% | 17,506 | -32,267 | -64.83% | 381,000 | Jun 30, 2024 |
| PALISADE CAPITAL MANAGEMENT, LP | 1.96% | 0.32% | 537,974 | -9,193 | -1.68% | 11,711,688 | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3.18% | 0.32% | 874,609 | -53,408 | -5.76% | 19,040,238 | Jun 30, 2024 |
| BRAIDWELL LP | 1.51% | 0.28% | 416,100 | 416,100 | 100.00% | 9,058,497 | Jun 30, 2024 |
| WASATCH ADVISORS LP | 8.47% | 0.27% | 2,327,936 | -223,152 | -8.75% | 50,679,167 | Jun 30, 2024 |
| INTRINSIC EDGE CAPITAL MANAGEMENT LLC | 0.47% | 0.26% | 130,000 | -20,000 | -13.33% | 2,830,100 | Jun 30, 2024 |
| HARBOR CAPITAL ADVISORS, INC. | 0.50% | 0.23% | 138,707 | 99,001 | 249.34% | 3,020,000 | Jun 30, 2024 |
The largest Castle Biosciences shareholder by % of total assets is ABG INNOVATION CAPITAL PARTNERS III GP LTD. The company owns 36.75K shares of Castle Biosciences (CSTL), representing 93.07% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | 1.67% | 0.00% | 460,000 | 460,000 | 100.00% | 10,014,200 | Jun 30, 2024 |
| BLACKROCK INC. | 11.08% | 0.00% | 3,044,973 | 449,286 | 17.31% | 66,289,062 | Jun 30, 2024 |
| BRAIDWELL LP | 1.51% | 0.28% | 416,100 | 416,100 | 100.00% | 9,058,497 | Jun 30, 2024 |
| PORTOLAN CAPITAL MANAGEMENT, LLC | 4.41% | 2.17% | 1,210,952 | 167,542 | 16.06% | 26,362,425 | Jun 30, 2024 |
| PURA VIDA INVESTMENTS, LLC | 0.56% | 2.11% | 153,386 | 153,386 | 100.00% | 3,339,213 | Jun 30, 2024 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 3.11% | 1.64% | 853,628 | 128,171 | 17.67% | 18,583,482 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 0.77% | 0.01% | 212,036 | 114,104 | 116.51% | 4,616,024 | Jun 30, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | 0.36% | 0.05% | 100,000 | 100,000 | 100.00% | 2,177,000 | Jun 30, 2024 |
| HARBOR CAPITAL ADVISORS, INC. | 0.50% | 0.23% | 138,707 | 99,001 | 249.34% | 3,020,000 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 1.04% | 0.00% | 286,511 | 96,883 | 51.09% | 6,237,344 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 1.10% | 0.01% | 301,500 | 96,800 | 47.29% | 6,563,655 | Jun 30, 2024 |
| LISANTI CAPITAL GROWTH, LLC | 0.35% | 0.51% | 96,550 | 96,550 | 100.00% | 2,101,894 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.79% | 0.00% | 217,137 | 92,465 | 74.17% | 4,727,073 | Jun 30, 2024 |
| VANGUARD GROUP INC | 5.74% | 0.00% | 1,577,514 | 83,338 | 5.58% | 34,342,480 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 1.02% | 0.02% | 280,497 | 69,673 | 33.05% | 6,101,000 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 2.95% | 0.00% | 809,934 | 60,675 | 8.10% | 17,630,935 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 0.20% | 0.00% | 53,777 | 53,777 | 100.00% | 1,170,724 | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | 1.13% | 0.00% | 309,511 | 46,703 | 17.77% | 6,738,054 | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 0.15% | 0.01% | 40,135 | 40,135 | 100.00% | 874,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.25% | 0.00% | 617,679 | 39,145 | 6.77% | 13,449,891 | Jun 30, 2024 |
As of Jun 30 2024, Castle Biosciences's largest institutional buyer is MILLENNIUM MANAGEMENT LLC. The company purchased 460.00K stocks of CSTL, valued at $10.01M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 3.85% | 0.92% | 1,058,941 | -568,283 | -34.92% | 23,053,146 | Jun 30, 2024 |
| MORGAN STANLEY | 0.91% | 0.00% | 249,380 | -401,331 | -61.68% | 5,429,003 | Jun 30, 2024 |
| WASATCH ADVISORS LP | 8.47% | 0.27% | 2,327,936 | -223,152 | -8.75% | 50,679,167 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.13% | 0.00% | 34,827 | -213,726 | -85.99% | 758,184 | Jun 30, 2024 |
| BANQUE PICTET & CIE SA | - | - | - | -166,881 | -100.00% | - | Jun 30, 2024 |
| INVENOMIC CAPITAL MANAGEMENT LP | - | - | - | -166,714 | -100.00% | - | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.19% | 0.01% | 51,247 | -114,194 | -69.02% | 1,115,646 | Jun 30, 2024 |
| PARKMAN HEALTHCARE PARTNERS LLC | 1.01% | 0.81% | 277,895 | -89,513 | -24.36% | 6,049,774 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.29% | 0.00% | 79,612 | -71,553 | -47.33% | 1,733,154 | Jun 30, 2024 |
| POLAR ASSET MANAGEMENT PARTNERS INC. | - | - | - | -60,800 | -100.00% | - | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3.18% | 0.32% | 874,609 | -53,408 | -5.76% | 19,040,238 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | - | - | - | -52,448 | -100.00% | - | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.10% | - | 26,168 | -49,975 | -65.63% | 569,677 | Jun 30, 2024 |
| NEW YORK STATE COMMON RETIREMENT FUND | 0.68% | 0.01% | 187,731 | -40,848 | -17.87% | 4,087,000 | Jun 30, 2024 |
| BARCLAYS PLC | 0.05% | 0.00% | 12,734 | -34,691 | -73.15% | 277,000 | Jun 30, 2024 |
| PRINCIPAL FINANCIAL GROUP INC | 5.45% | 0.02% | 1,498,143 | -34,329 | -2.24% | 32,614,493,000 | Jun 30, 2024 |
| MILLRACE ASSET GROUP, INC. | 0.06% | 0.37% | 17,506 | -32,267 | -64.83% | 381,000 | Jun 30, 2024 |
| NORDEN GROUP LLC | - | - | - | -24,673 | -100.00% | - | Jun 30, 2024 |
| AQR CAPITAL MANAGEMENT LLC | - | - | - | -22,795 | -100.00% | - | Jun 30, 2024 |
| CAPITAL IMPACT ADVISORS, LLC | - | - | - | -22,713 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Castle Biosciences's biggest institutional seller is GRANAHAN INVESTMENT MANAGEMENT, LLC. The company sold -0.57M shares of CSTL, valued at $23.05M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | 1.67% | 0.00% | 460,000 | 460,000 | 100.00% | 10,014,200 | Jun 30, 2024 |
| BRAIDWELL LP | 1.51% | 0.28% | 416,100 | 416,100 | 100.00% | 9,058,497 | Jun 30, 2024 |
| PURA VIDA INVESTMENTS, LLC | 0.56% | 2.11% | 153,386 | 153,386 | 100.00% | 3,339,213 | Jun 30, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | 0.36% | 0.05% | 100,000 | 100,000 | 100.00% | 2,177,000 | Jun 30, 2024 |
| LISANTI CAPITAL GROWTH, LLC | 0.35% | 0.51% | 96,550 | 96,550 | 100.00% | 2,101,894 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 0.20% | 0.00% | 53,777 | 53,777 | 100.00% | 1,170,724 | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 0.15% | 0.01% | 40,135 | 40,135 | 100.00% | 874,000 | Jun 30, 2024 |
| INSPIRE INVESTING, LLC | 0.14% | 0.09% | 37,167 | 37,167 | 100.00% | 809,126 | Jun 30, 2024 |
| CAMPBELL & CO INVESTMENT ADVISER LLC | 0.10% | 0.05% | 27,033 | 27,033 | 100.00% | 588,508 | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | 0.10% | 0.00% | 26,989 | 26,989 | 100.00% | 588,000 | Jun 30, 2024 |
| SUMMIT GLOBAL INVESTMENTS | 0.09% | 0.03% | 23,812 | 23,812 | 100.00% | 518,000 | Jun 30, 2024 |
| CRESSET ASSET MANAGEMENT, LLC | 0.07% | 0.00% | 18,710 | 18,710 | 100.00% | 407,317 | Jun 30, 2024 |
| 0.05% | 0.04% | 14,756 | 14,756 | 100.00% | 322,419 | Jun 30, 2024 | |
| THRIVENT FINANCIAL FOR LUTHERANS | 0.05% | 0.00% | 14,738 | 14,738 | 100.00% | 321,000 | Jun 30, 2024 |
| LEGATO CAPITAL MANAGEMENT LLC | 0.05% | 0.04% | 14,155 | 14,155 | 100.00% | 308,154 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.05% | 0.00% | 13,917 | 13,917 | 100.00% | 302,973 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.05% | 0.00% | 13,016 | 13,016 | 100.00% | 283,358 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | 0.02% | 0.00% | 5,600 | 5,600 | 100.00% | 121,912 | Jun 30, 2024 |
| TORNO CAPITAL, LLC | 0.02% | 0.01% | 5,000 | 5,000 | 100.00% | 108,850 | Jun 30, 2024 |
| HARBOUR INVESTMENTS, INC. | 0.01% | 0.00% | 2,270 | 2,270 | 100.00% | 49,418 | Jun 30, 2024 |
| COPPELL ADVISORY SOLUTIONS LLC | 0.01% | 0.01% | 2,043 | 2,043 | 100.00% | 44,476 | Jun 30, 2024 |
| C M BIDWELL & ASSOCIATES LTD | 0.01% | 0.02% | 1,655 | 1,655 | 100.00% | 36,029 | Jun 30, 2024 |
| OPAL WEALTH ADVISORS, LLC | 0.00% | 0.00% | 339 | 339 | 100.00% | 7,381 | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 0.00% | 0.00% | 253 | 253 | 100.00% | 5,502 | Jun 30, 2024 |
| CWM, LLC | 0.00% | - | 117 | 117 | 100.00% | 3,000 | Jun 30, 2024 |
| FINANCIAL NETWORK WEALTH ADVISORS LLC | 0.00% | 0.00% | 113 | 113 | 100.00% | 2,460 | Jun 30, 2024 |
| IBEX WEALTH ADVISORS | 0.00% | 0.00% | 50 | 50 | 100.00% | 1,089 | Jun 30, 2024 |
| SRS CAPITAL ADVISORS, INC. | 0.00% | 0.00% | 31 | 31 | 100.00% | 675 | Jun 30, 2024 |
| ROTHSCHILD INVESTMENT LLC | 0.00% | - | 15 | 15 | 100.00% | 327 | Jun 30, 2024 |
| EVERSOURCE WEALTH ADVISORS, LLC | - | - | 7 | 7 | 100.00% | 169 | Jun 30, 2024 |
| PLANNING CAPITAL MANAGEMENT CORP | - | - | 1 | 1 | 100.00% | 22 | Jun 30, 2024 |
Castle Biosciences's largest new institutional shareholder by number of shares is MILLENNIUM MANAGEMENT LLC, purchased 460.00K shares, valued at $10.01M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BANQUE PICTET & CIE SA | - | - | - | -166,881 | -100.00% | - | Jun 30, 2024 |
| INVENOMIC CAPITAL MANAGEMENT LP | - | - | - | -166,714 | -100.00% | - | Jun 30, 2024 |
| POLAR ASSET MANAGEMENT PARTNERS INC. | - | - | - | -60,800 | -100.00% | - | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | - | - | - | -52,448 | -100.00% | - | Jun 30, 2024 |
| NORDEN GROUP LLC | - | - | - | -24,673 | -100.00% | - | Jun 30, 2024 |
| AQR CAPITAL MANAGEMENT LLC | - | - | - | -22,795 | -100.00% | - | Jun 30, 2024 |
| CAPITAL IMPACT ADVISORS, LLC | - | - | - | -22,713 | -100.00% | - | Jun 30, 2024 |
| SHERBROOKE PARK ADVISERS LLC | - | - | - | -20,825 | -100.00% | - | Jun 30, 2024 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | - | - | - | -18,201 | -100.00% | - | Jun 30, 2024 |
| NEW YORK LIFE INVESTMENT MANAGEMENT LLC | - | - | - | -16,516 | -100.00% | - | Jun 30, 2024 |
| HRT FINANCIAL LP | - | - | - | -15,011 | -100.00% | - | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | - | - | - | -14,748 | -100.00% | - | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | - | - | - | -13,382 | -100.00% | - | Jun 30, 2024 |
| PICTET & CIE (EUROPE) SA | - | - | - | -12,897 | -100.00% | - | Jun 30, 2024 |
| DIVERSIFY ADVISORY SERVICES, LLC | - | - | - | -12,498 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -12,244 | -100.00% | - | Jun 30, 2024 |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | - | - | - | -10,954 | -100.00% | - | Jun 30, 2024 |
| VERSOR INVESTMENTS LP | - | - | - | -10,238 | -100.00% | - | Jun 30, 2024 |
| JANUS HENDERSON GROUP PLC | - | - | - | -9,266 | -100.00% | - | Jun 30, 2024 |
| DENALI ADVISORS LLC | - | - | - | -8,400 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -1,410 | -100.00% | - | Jun 30, 2024 |
| PNC FINANCIAL SERVICES GROUP, INC. | - | - | - | -38 | -100.00% | - | Jun 30, 2024 |
Castle Biosciences's largest sold out institutional shareholder by shares sold is BANQUE PICTET & CIE SA, sold -0.17M shares, valued at -, as of undefined.
Castle Biosciences Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| SPARROW FUNDS | 1.59% | 5,675 | - | - | Feb 29, 2024 |
| NEIMAN FUNDS | 0.37% | 58,900 | 12,000 | 25.59% | Mar 31, 2024 |
| WASATCH FUNDS TRUST | 0.21% | 1,946,169 | -74,588 | -3.69% | Mar 31, 2024 |
| NUVEEN INVESTMENT TRUST | 0.18% | 102,983 | - | - | Mar 31, 2024 |
| ALLSPRING VARIABLE TRUST | 0.17% | 102,436 | - | - | Mar 31, 2024 |
| ALGER FUNDS | 0.11% | 101,957 | - | - | Jan 31, 2024 |
| STATE STREET INSTITUTIONAL FUNDS | 0.10% | 80,395 | -2,561 | -3.09% | Mar 31, 2024 |
| BUFFALO FUNDS | 0.08% | 542,874 | - | - | Mar 31, 2024 |
| EntrepreneurShares Series Trust | 0.06% | 16,554 | - | - | Dec 31, 2023 |
| SARATOGA ADVANTAGE TRUST | 0.05% | 2,834 | - | - | Feb 29, 2024 |
| MERIDIAN FUND INC | 0.05% | 106,531 | - | - | Mar 28, 2024 |
| Monteagle Funds | 0.04% | 1,706 | - | - | Feb 29, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.03% | 17,567 | - | - | Mar 31, 2024 |
| AIM FUNDS GROUP (INVESCO FUNDS GROUP) | 0.03% | 152,201 | - | - | Mar 31, 2024 |
| Humankind Benefit Corp | 0.03% | 660 | -68 | -9.34% | Dec 31, 2023 |
| ROYCE MICRO-CAP TRUST, INC. | 0.02% | 11,125 | -20,517 | -64.84% | Mar 31, 2024 |
| OBERWEIS FUNDS | 0.02% | 23,000 | - | - | Mar 31, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.02% | 40,559 | - | - | Mar 31, 2024 |
| Voya EQUITY TRUST | 0.02% | 25,998 | - | - | Feb 29, 2024 |
| Vericimetry Funds | 0.02% | 1,480 | - | - | Mar 31, 2024 |
| Collaborative Investment Series Trust | 0.02% | 2,436 | - | - | Mar 31, 2024 |
| FORUM FUNDS II | 0.01% | 12,904 | -6,197 | -32.44% | Mar 31, 2024 |
| AIM INTERNATIONAL MUTUAL FUNDS (INVESCO INTERNATIONAL MUTUAL FUNDS) | 0.01% | 430,219 | - | - | Jan 31, 2024 |
| LORD ABBETT SECURITIES TRUST | 0.01% | 55,920 | - | - | Jan 31, 2024 |
| AMG Funds I | 0.01% | 19,562 | - | - | Jan 31, 2024 |
| NORTHERN LIGHTS FUND TRUST II | 0.01% | 106,785 | -69,293 | -39.35% | Jan 31, 2024 |
| MADISON FUNDS | 0.01% | 53,433 | - | - | Jan 31, 2024 |
| LKCM Funds | 0.01% | 34,275 | - | - | Mar 31, 2024 |
| SunAmerica Specialty Series | 0.01% | 4,007 | - | - | Apr 30, 2021 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 44,202 | -2,057 | -4.45% | Mar 31, 2024 |
| Federated Hermes Equity Funds | 0.01% | 139,747 | - | - | Jan 31, 2024 |
| Destra Investment Trust | 0.01% | 11,465 | -2,797 | -19.61% | Mar 31, 2024 |
| FORUM FUNDS | 0.01% | 15,190 | - | - | Jan 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 3,852 | - | - | Mar 31, 2024 |
| DRIEHAUS MUTUAL FUNDS | 0.01% | 52,740 | - | - | Mar 28, 2024 |
| ROYCE FUND | 0.01% | 35,000 | - | - | Mar 31, 2024 |
| Nushares ETF Trust | 0.00% | 30,600 | -695 | -2.22% | Jan 31, 2024 |
| UBS FUNDS | 0.00% | 20,006 | - | - | Mar 31, 2024 |
| FINANCIAL INVESTORS TRUST | 0.00% | 326,005 | - | - | Jan 31, 2024 |
| Securian Funds Trust | 0.00% | 36,323 | - | - | Mar 31, 2024 |
| VIRTUS ASSET TRUST | 0.00% | 88,450 | - | - | Mar 28, 2024 |
| Segall Bryant & Hamill Trust | 0.00% | 60,781 | - | - | Mar 31, 2024 |
| Ivy Variable Insurance Portfolios | 0.00% | 73,128 | - | - | Mar 28, 2024 |
| AMG FUNDS | 0.00% | 87,840 | - | - | Mar 28, 2024 |
| Columbia Funds Variable Series Trust II | 0.00% | 96,760 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 1,197,609 | -387,094 | -24.43% | Mar 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 627 | - | - | Mar 31, 2024 |
| Harbor ETF Trust | 0.00% | 11,983 | 2,178 | 22.21% | Jan 31, 2024 |
| Federated Hermes MDT Series | 0.00% | 5,036 | - | - | Jan 31, 2024 |
| FIDELITY SECURITIES FUND | 0.00% | 180,658 | - | - | Jan 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND | 0.00% | 7,150 | - | - | Jan 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 69,650 | - | - | Jan 31, 2024 |
| AdvisorShares Trust | 0.00% | 6,613 | - | - | Mar 28, 2024 |
| AMERICAN CENTURY QUANTITATIVE EQUITY FUNDS, INC. | 0.00% | 3,621 | - | - | Mar 31, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 100,056 | - | - | Feb 29, 2024 |
| VANGUARD EXPLORER FUND | 0.00% | 18,657 | - | - | Jan 31, 2024 |
| IVY FUNDS | 0.00% | 477,630 | - | - | Mar 28, 2024 |
| CLEARWATER INVESTMENT TRUST | 0.00% | 13,222 | - | - | Mar 28, 2024 |
| PRINCIPAL VARIABLE CONTRACTS FUNDS INC | 0.00% | 50,500 | -4,500 | -8.18% | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 256,389 | 10,890 | 4.44% | Feb 29, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 4,668 | - | - | Mar 31, 2024 |
| KP Funds | 0.00% | 50,606 | 5,271 | 11.63% | Sep 30, 2020 |
| CALAMOS INVESTMENT TRUST/IL | 0.00% | 115,045 | - | - | Jan 31, 2024 |
| Ultimus Managers Trust | 0.00% | 12,242 | - | - | Feb 29, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.00% | 3,211 | - | - | Feb 29, 2024 |
| AMG FUNDS III | 0.00% | 5,011 | - | - | Mar 28, 2024 |
| North Square Investments Trust | 0.00% | 8,840 | 4,660 | 111.48% | Feb 29, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 2,450 | - | - | Mar 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 183,682 | -45,674 | -19.91% | Jan 31, 2024 |
| VANGUARD HORIZON FUNDS | 0.00% | 16,771 | -15,184 | -47.52% | Mar 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 12,998 | -210 | -1.59% | Jan 31, 2024 |
| Voya PARTNERS INC | 0.00% | 51,528 | - | - | Mar 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 3,032 | -197 | -6.10% | Mar 31, 2024 |
| MAINSTAY VP FUNDS TRUST | 0.00% | 77,097 | - | - | Mar 31, 2024 |
| Fidelity Commonwealth Trust II | 0.00% | 4,000 | - | - | Aug 31, 2023 |
| NORTHERN LIGHTS FUND TRUST III | 0.00% | 6,273 | 1,646 | 35.57% | Mar 31, 2024 |
| Dimensional ETF Trust | 0.00% | 229,982 | 39,471 | 20.72% | Jan 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 6,186 | - | - | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 13,934 | -1,237 | -8.15% | Mar 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 61,039 | - | - | Mar 31, 2024 |
| SSGA FUNDS | 0.00% | 170 | - | - | Feb 29, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 383,550 | 111,355 | 40.91% | Jan 31, 2024 |
| PUTNAM ASSET ALLOCATION FUNDS | 0.00% | 11,927 | -187 | -1.54% | Mar 31, 2024 |
| LoCorr Investment Trust | 0.00% | 9,289 | -8,550 | -47.93% | Mar 31, 2024 |
| MASSMUTUAL PREMIER FUNDS | 0.00% | 10,186 | - | - | Dec 31, 2023 |
| BMO FUNDS, INC. | 0.00% | 14,372 | -1,440 | -9.11% | Nov 30, 2021 |
| VANGUARD WORLD FUND | 0.00% | 86,469 | 450 | 0.52% | Feb 29, 2024 |
| PUTNAM FUNDS TRUST | 0.00% | 72,995 | - | - | Jan 31, 2024 |
| Janus Detroit Street Trust | 0.00% | 51,072 | - | - | Jan 31, 2024 |
| Virtus Strategy Trust | 0.00% | 6,299 | - | - | Mar 28, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 6,185 | 94 | 1.54% | Mar 31, 2024 |
| Fidelity Rutland Square Trust II | 0.00% | 329,861 | - | - | Feb 29, 2024 |
| Meeder Funds | 0.00% | 1,294 | - | - | Mar 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 30,324 | 10,458 | 52.64% | Feb 29, 2024 |
| TIMOTHY PLAN | 0.00% | 1,228 | - | - | Mar 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 8,298 | -1,889 | -18.54% | Mar 31, 2024 |
| Global X Funds | 0.00% | 10,917 | - | - | Jan 31, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 141,616 | 8,485 | 6.37% | Feb 29, 2024 |
| Advisors' Inner Circle Fund III | 0.00% | 26,716 | 378 | 1.44% | Jan 31, 2024 |
| Legg Mason ETF Investment Trust | 0.00% | 432 | - | - | Mar 31, 2024 |
Castle Biosciences's largest mutual fund holder by % of total assets is "SPARROW FUNDS", owning 5.67K shares, compromising 1.59% of its total assets.
Castle Biosciences Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 67 | -55.92% |
| 31 Mar, 24 | 152 | -0.65% |
| 31 Dec, 23 | 153 | 12.50% |
| 30 Sep, 23 | 136 | 1.49% |
| 30 Jun, 23 | 134 | -10.67% |
| 31 Mar, 23 | 150 | -3.23% |
| 31 Dec, 22 | 155 | -3.13% |
| 30 Sep, 22 | 160 | 10.34% |
| 30 Jun, 22 | 145 | -7.05% |
| 31 Mar, 22 | 156 | -1.27% |
| 31 Dec, 21 | 158 | -15.96% |
| 30 Sep, 21 | 188 | 3.30% |
| 30 Jun, 21 | 182 | 3.41% |
| 31 Mar, 21 | 176 | 2.33% |
| 31 Dec, 20 | 172 | 17.81% |
| 30 Sep, 20 | 146 | 16.80% |
| 30 Jun, 20 | 125 | 42.05% |
| 31 Mar, 20 | 88 | 33.33% |
| 31 Dec, 19 | 66 | 15.79% |
| 30 Sep, 19 | 57 | - |
As of 30 Jun 24, 67 institutions are holding Castle Biosciences's shares, representing a decrease of -55.92% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 6,077,773 | -75.63% |
| 31 Mar, 24 | 24,935,063 | 4.70% |
| 31 Dec, 23 | 23,814,798 | 3.24% |
| 30 Sep, 23 | 23,066,449 | 0.30% |
| 30 Jun, 23 | 22,998,186 | 4.23% |
| 31 Mar, 23 | 22,064,743 | -0.46% |
| 31 Dec, 22 | 22,166,113 | 1.41% |
| 30 Sep, 22 | 21,857,007 | -3.11% |
| 30 Jun, 22 | 22,558,827 | -0.87% |
| 31 Mar, 22 | 22,756,848 | 6.31% |
| 31 Dec, 21 | 21,406,424 | -0.25% |
| 30 Sep, 21 | 21,460,694 | 3.39% |
| 30 Jun, 21 | 20,756,192 | -2.50% |
| 31 Mar, 21 | 21,289,438 | 6.55% |
| 31 Dec, 20 | 19,980,383 | 49.16% |
| 30 Sep, 20 | 13,394,956 | 14.39% |
| 30 Jun, 20 | 11,710,315 | 59.11% |
| 31 Mar, 20 | 7,359,743 | 44.06% |
| 31 Dec, 19 | 5,108,855 | 4.92% |
| 30 Sep, 19 | 4,869,196 | - |
Castle Biosciences (CSTL) has 6.08M shares outstanding as of 30 Jun 24, down -75.63% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 22.11% | 0.26% |
| 31 Mar, 24 | 92.25% | 1.17% |
| 31 Dec, 23 | 88.75% | 1.19% |
| 30 Sep, 23 | 86.28% | 1.15% |
| 30 Jun, 23 | 86.44% | 1.26% |
| 31 Mar, 23 | 82.93% | 1.15% |
| 31 Dec, 22 | 85.08% | 1.23% |
| 30 Sep, 22 | 83.06% | 1.11% |
| 30 Jun, 22 | 86.55% | 1.08% |
| 31 Mar, 22 | 89.51% | 1.23% |
| 31 Dec, 21 | 85.16% | 1.18% |
| 30 Sep, 21 | 84.87% | 1.24% |
| 30 Jun, 21 | 82.72% | 1.13% |
| 31 Mar, 21 | 85.46% | 0.93% |
| 31 Dec, 20 | 95.91% | 2.12% |
| 30 Sep, 20 | 67.19% | 1.51% |
| 30 Jun, 20 | 66.75% | 3.72% |
| 31 Mar, 20 | 42.37% | 4.86% |
| 31 Dec, 19 | 29.54% | 2.03% |
| 30 Sep, 19 | 38.17% | - |
As of 30 Jun 24, Castle Biosciences is held by 22.11% institutional shareholders, representing a 0.26% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 34 | -52.78% |
| 31 Mar, 24 | 72 | -21.74% |
| 31 Dec, 23 | 92 | 26.03% |
| 30 Sep, 23 | 73 | -14.12% |
| 30 Jun, 23 | 85 | 8.97% |
| 31 Mar, 23 | 78 | 4.00% |
| 31 Dec, 22 | 75 | -7.41% |
| 30 Sep, 22 | 81 | -17.35% |
| 30 Jun, 22 | 98 | 5.38% |
| 31 Mar, 22 | 93 | 10.71% |
| 31 Dec, 21 | 84 | -16.00% |
| 30 Sep, 21 | 100 | -13.04% |
| 30 Jun, 21 | 115 | 9.52% |
| 31 Mar, 21 | 105 | -0.94% |
| 31 Dec, 20 | 106 | 13.98% |
| 30 Sep, 20 | 93 | -3.13% |
| 30 Jun, 20 | 96 | 41.18% |
| 31 Mar, 20 | 68 | 36.00% |
| 31 Dec, 19 | 50 | -12.28% |
| 30 Sep, 19 | 57 | - |
34 institutional shareholders have increased their position in CSTL stock as of 30 Jun 24 compared to 72 in the previous quarter (a -52.78% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 18 | -66.67% |
| 31 Mar, 24 | 54 | 25.58% |
| 31 Dec, 23 | 43 | 7.50% |
| 30 Sep, 23 | 40 | 60.00% |
| 30 Jun, 23 | 25 | -30.56% |
| 31 Mar, 23 | 36 | -34.55% |
| 31 Dec, 22 | 55 | 14.58% |
| 30 Sep, 22 | 48 | 71.43% |
| 30 Jun, 22 | 28 | -31.71% |
| 31 Mar, 22 | 41 | -14.58% |
| 31 Dec, 21 | 48 | -9.43% |
| 30 Sep, 21 | 53 | 26.19% |
| 30 Jun, 21 | 42 | -22.22% |
| 31 Mar, 21 | 54 | 22.73% |
| 31 Dec, 20 | 44 | 18.92% |
| 30 Sep, 20 | 37 | 131.25% |
| 30 Jun, 20 | 16 | 14.29% |
| 31 Mar, 20 | 14 | 16.67% |
| 31 Dec, 19 | 12 | - |
| 30 Sep, 19 | - | - |
18 institutional shareholders have reduced their position in CSTL stock as of 30 Jun 24 compared to 54 in the previous quarter (a -66.67% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 67 | -55.92% | 6,077,773 | -75.63% | 22.11% | 0.26% | 34 | -52.78% | 18 | -66.67% |
| 31 Mar, 24 | 152 | -0.65% | 24,935,063 | 4.70% | 92.25% | 1.17% | 72 | -21.74% | 54 | 25.58% |
| 31 Dec, 23 | 153 | 12.50% | 23,814,798 | 3.24% | 88.75% | 1.19% | 92 | 26.03% | 43 | 7.50% |
| 30 Sep, 23 | 136 | 1.49% | 23,066,449 | 0.30% | 86.28% | 1.15% | 73 | -14.12% | 40 | 60.00% |
| 30 Jun, 23 | 134 | -10.67% | 22,998,186 | 4.23% | 86.44% | 1.26% | 85 | 8.97% | 25 | -30.56% |
| 31 Mar, 23 | 150 | -3.23% | 22,064,743 | -0.46% | 82.93% | 1.15% | 78 | 4.00% | 36 | -34.55% |
| 31 Dec, 22 | 155 | -3.13% | 22,166,113 | 1.41% | 85.08% | 1.23% | 75 | -7.41% | 55 | 14.58% |
| 30 Sep, 22 | 160 | 10.34% | 21,857,007 | -3.11% | 83.06% | 1.11% | 81 | -17.35% | 48 | 71.43% |
| 30 Jun, 22 | 145 | -7.05% | 22,558,827 | -0.87% | 86.55% | 1.08% | 98 | 5.38% | 28 | -31.71% |
| 31 Mar, 22 | 156 | -1.27% | 22,756,848 | 6.31% | 89.51% | 1.23% | 93 | 10.71% | 41 | -14.58% |
| 31 Dec, 21 | 158 | -15.96% | 21,406,424 | -0.25% | 85.16% | 1.18% | 84 | -16.00% | 48 | -9.43% |
| 30 Sep, 21 | 188 | 3.30% | 21,460,694 | 3.39% | 84.87% | 1.24% | 100 | -13.04% | 53 | 26.19% |
| 30 Jun, 21 | 182 | 3.41% | 20,756,192 | -2.50% | 82.72% | 1.13% | 115 | 9.52% | 42 | -22.22% |
| 31 Mar, 21 | 176 | 2.33% | 21,289,438 | 6.55% | 85.46% | 0.93% | 105 | -0.94% | 54 | 22.73% |
| 31 Dec, 20 | 172 | 17.81% | 19,980,383 | 49.16% | 95.91% | 2.12% | 106 | 13.98% | 44 | 18.92% |
| 30 Sep, 20 | 146 | 16.80% | 13,394,956 | 14.39% | 67.19% | 1.51% | 93 | -3.13% | 37 | 131.25% |
| 30 Jun, 20 | 125 | 42.05% | 11,710,315 | 59.11% | 66.75% | 3.72% | 96 | 41.18% | 16 | 14.29% |
| 31 Mar, 20 | 88 | 33.33% | 7,359,743 | 44.06% | 42.37% | 4.86% | 68 | 36.00% | 14 | 16.67% |
| 31 Dec, 19 | 66 | 15.79% | 5,108,855 | 4.92% | 29.54% | 2.03% | 50 | -12.28% | 12 | - |
| 30 Sep, 19 | 57 | - | 4,869,196 | - | 38.17% | - | 57 | - | - | - |
Castle Biosciences Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Castle Biosciences's stock was made by BRADBURY DANIEL on Aug 14 2024, selling 5,021 shares at $26.65 per share (valued at $133.79K).
Castle Biosciences Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 13 | 15 | 86.67% |
| Q2 2024 | 15 | 59 | 25.42% |
| Q1 2024 | 8 | 43 | 18.60% |
| Q4 2023 | 15 | 205 | 7.32% |
| Q3 2023 | 2 | 42 | 4.76% |
| Q2 2023 | 18 | 74 | 24.32% |
| Q1 2023 | 1 | 61 | 1.64% |
| Q4 2022 | 17 | 120 | 14.17% |
| Q3 2022 | - | 117 | - |
| Q2 2022 | 25 | 5 | 500.00% |
| Q1 2022 | - | 37 | - |
| Q4 2021 | 15 | 106 | 14.15% |
| Q3 2021 | 6 | 266 | 2.26% |
| Q2 2021 | 18 | 126 | 14.29% |
| Q1 2021 | 2 | 190 | 1.05% |
| Q4 2020 | 9 | 175 | 5.14% |
| Q3 2020 | 1 | 147 | 0.68% |
| Q2 2020 | 14 | 96 | 14.58% |
| Q1 2020 | - | 12 | - |
| Q4 2019 | 4 | - | - |
13 total buy trades, and 15 total sell trades (buy/sell ratio of 0.87%) were made by Castle Biosciences's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 8 | - |
| Q2 2024 | - | 51 | - |
| Q1 2024 | - | 40 | - |
| Q4 2023 | - | 178 | - |
| Q3 2023 | - | 40 | - |
| Q2 2023 | 2 | 65 | 3.08% |
| Q1 2023 | - | 60 | - |
| Q4 2022 | 1 | 100 | 1.00% |
| Q3 2022 | - | 115 | - |
| Q2 2022 | 2 | - | - |
| Q1 2022 | - | 36 | - |
| Q4 2021 | - | 94 | - |
| Q3 2021 | - | 264 | - |
| Q2 2021 | - | 86 | - |
| Q1 2021 | - | 187 | - |
| Q4 2020 | - | 170 | - |
| Q3 2020 | - | 145 | - |
| Q2 2020 | - | 92 | - |
| Q1 2020 | - | 12 | - |
| Q4 2019 | - | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 8 open market sell trades of Castle Biosciences's stocks.
Castle Biosciences Peer Ownership
| Ticker | Company |
|---|---|
| GTH | Genetron Holdings Limited |
| PSNL | Personalis, Inc. |
| GH | Guardant Health, Inc. |
| CDNA | CareDx, Inc |
| NTRA | Natera, Inc. |
| XGN | Exagen Inc. |
| LMDX | LumiraDx Limited |
| TWST | Twist Bioscience Corporation |
| SERA | Sera Prognostics, Inc. |
| ENZ | Enzo Biochem, Inc. |
| BNR | Burning Rock Biotech Limited |
| OLK | Olink Holding AB (publ) |
| BDSX | Biodesix, Inc. |
| FONR | FONAR Corporation |
| STIM | Neuronetics, Inc. |
CSTL Ownership FAQ
Who Owns Castle Biosciences?
Castle Biosciences is owned by institutional shareholders (22.11%), insiders (3.32%), and public (74.57%). The largest institutional shareholder of Castle Biosciences is BLACKROCK INC. (11.08% of total shares) and the top mutual fund owner is SPARROW FUNDS (1.59% of total shares).
Who are the major institutional shareholders of Castle Biosciences?
Castle Biosciences's major institutional shareholders are BLACKROCK INC., WASATCH ADVISORS LP, VANGUARD GROUP INC, PRINCIPAL FINANCIAL GROUP INC, and BELLEVUE GROUP AG. The top five shareholders own together 35.17% of the company's share outstanding.
How many Castle Biosciences shareholders are there?
As of Jun 2024, there are 67 institutional shareholders of Castle Biosciences.
What percentage of Castle Biosciences is owned by BLACKROCK INC?
BLACKROCK INC owns 3.04M shares of Castle Biosciences, representing 11.08% of the company's total shares outstanding, valued at $66.29M (as of Jun 2024).
What percentage of Castle Biosciences is owned by WASATCH ADVISORS LP?
As of Jun 2024, WASATCH ADVISORS LP holds 2.33M shares of Castle Biosciences (CSTL), compromising 8.47% of the company, valued at $50.68M.
What percentage of Castle Biosciences is owned by VANGUARD GROUP INC?
VANGUARD GROUP INC is the third largest holder of Castle Biosciences. The company owns 1.58M of the company's shares outstanding (worth $34.34M).